Involvement of the mismatch repair system in temozolomide-induced apoptosis

S D'Atri, L Tentori, PM Lacal, G Graziani, E Pagani… - Molecular …, 1998 - ASPET
Postreplicative mismatch repair plays a major role in mediating the cytotoxicity of agents
generatingO 6 -methylguanine in DNA. We previously showed that a methylating antitumor …

[HTML][HTML] Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models

C Ceci, MG Atzori, PM Lacal, G Graziani - International journal of …, 2020 - mdpi.com
The vascular endothelial growth factor (VEGF) family members, VEGF-A, placenta growth
factor (PlGF), and to a lesser extent VEGF-B, play an essential role in tumor-associated …

Poly (ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis

L Tentori, PM Lacal, A Muzi, AS Dorio… - European Journal of …, 2007 - Elsevier
Poly(ADP-ribose) polymerase (PARP)-1 has recently been shown to promote tumour
progression. Since angiogenesis is an essential requirement for tumour growth, we examined …

Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non …

PM Lacal, G Graziani - Pharmacological research, 2018 - Elsevier
… Author links open overlay panel Pedro Miguel Lacal a , Grazia Graziani b … In contrast,
M2 TAMs are originated in the presence of growth factors such as M-CSF and of CD4+T cell-…

Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules …

L Lisi, PM Lacal, M Martire, P Navarra… - Pharmacological …, 2022 - Elsevier
The immune checkpoint cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is an inhibitory
regulator of T-cell mediated responses that has been investigated as target of monoclonal …

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential

…, L Brogelli, F Sera, PM Lacal, M Pesce… - The American journal of …, 2006 - Elsevier
Reduced microcirculation and diminished expression of growth factors contribute to wound
healing impairment in diabetes. Placenta growth factor (PlGF), an angiogenic mediator …

Challenging resistance mechanisms to therapies for metastatic melanoma

L Tentori, PM Lacal, G Graziani - Trends in pharmacological sciences, 2013 - cell.com
Melanoma is the most aggressive form of skin cancer and, if spread outside the epidermis,
has a dismal prognosis. Before the approval of the anti-cytotoxic T lymphocyte-associated …

Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for theα5β1 integrin

A Orecchia, PM Lacal, C Schietroma… - Journal of cell …, 2003 - journals.biologists.com
Vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine kinase receptor for
several growth factors of the VEGF family. Endothelial cells express a membrane-spanning …

[HTML][HTML] Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid

C Ceci, PM Lacal, L Tentori, MG De Martino, R Miano… - Nutrients, 2018 - mdpi.com
Ellagic acid (EA) is a naturally occurring polyphenolic compound endowed with strong
antioxidant and anticancer properties that is present in high quantity in a variety of berries, …

[HTML][HTML] Targeting tumor-associated macrophages to increase the efficacy of immune checkpoint inhibitors: a glimpse into novel therapeutic approaches for metastatic …

C Ceci, MG Atzori, PM Lacal, G Graziani - Cancers, 2020 - mdpi.com
Simple Summary Stimulation of the host immune responses, through the use of biotech
drugs that remove a brake on the immune system (immune checkpoint inhibitors), is a current …